Vantage Consulting Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-921
Closed -$296K 78
2024
Q2
$296K Sell
921
-54
-6% -$17.5K 0.22% 78
2024
Q1
$325K Sell
975
-236
-19% -$72.1K 0.21% 71
2023
Q4
$328K Buy
1,211
+8
+0.7% +$1.98K 0.22% 66
2023
Q3
$296K Sell
1,203
-1
-0.1% -$274 0.2% 90
2023
Q2
$365K Sell
1,204
-170
-12% -$47.3K 0.21% 61
2023
Q1
$362K Sell
1,374
-66
-5% -$16.8K 0.21% 74
2022
Q4
$346K Sell
1,440
-220
-13% -$49.3K 0.2% 67
2022
Q3
$305K Sell
1,660
-74
-4% -$14.7K 0.18% 78
2022
Q2
$291K Buy
1,734
+515
+42% +$111K 0.16% 88
2022
Q1
$306K Sell
1,219
-295
-19% -$74.1K 0.12% 94
2021
Q4
$389K Buy
1,514
+175
+13% +$42.8K 0.1% 67
2021
Q3
$325K Buy
1,339
+274
+26% +$67K 0.07% 83
2021
Q2
$220K Buy
+1,065
New +$217K 0.04% 181
2021
Q1
Sell
-678
Closed -$112K 720
2020
Q4
$112K Buy
+678
New +$99.1K 0.01% 150

Other funds holding HCA

Vantage Consulting Group's HCA Position: Q3 2024 in Review

Vantage Consulting Group sold out of HCA Healthcare (HCA) in Q3 2024, closing a stake of 921 shares — an estimated $296K sold.

Vantage Consulting Group first reported a position in HCA in Q4 2020 and held it in 14 quarters. The position peaked at $389K in Q4 2021. 1,203 funds tracked by Wall St. Rank hold HCA as of Q3 2024.

  • Vantage Consulting Group reported no remaining HCA Healthcare position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 921 HCA Healthcare shares in Q3 2024, an estimated $296K.
  • Vantage Consulting Group first reported a position in HCA Healthcare in Q4 2020 and held it in 14 quarters.
  • Vantage Consulting Group's HCA Healthcare position peaked at $389K in Q4 2021.
  • 1,203 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.